Group 6 Copy 235
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    Part 2: Can low carbohydrate ketogenic diets inhibit cancers?

    We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...

    Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

    One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

    Backer Badge Funded